Tiverton Asset Management’s Dianthus Therapeutics DNTH Stock Holding History

Tiverton Asset Management’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$96K	Hold	588	–	–	﹤0.01%	647
2019 Q2	$139K	Hold	588	–	–	0.01%	591
2019 Q1	$155K	Hold	588	–	–	0.01%	543
2018 Q4	$54K	Buy	588 +9	+2%	+$1.23K	﹤0.01%	442
2018 Q3	$111K	Hold	579	–	–	0.01%	362
2018 Q2	$125K	Buy	+579	New	+$131K	0.01%	357

Other funds holding DNTH

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return